BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-12-21
DOI
10.1038/srep39743
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- β-Catenin is involved in Bex2 down-regulation induced glioma cell invasion/migration inhibition
- (2015) Er Nie et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Does growing vegetables in plastic greenhouses enhance regional ecosystem services beyond the food supply?
- (2013) Jie Chang et al. FRONTIERS IN ECOLOGY AND THE ENVIRONMENT
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- MiR-21 Modulates hTERT Through a STAT3-Dependent Manner on Glioblastoma Cell Growth
- (2012) Ying-Yi Wang et al. CNS Neuroscience & Therapeutics
- Transcriptional Network Analysis Identifies BACH1 as a Master Regulator of Breast Cancer Bone Metastasis
- (2012) Yajun Liang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells
- (2012) K. Bajbouj et al. JOURNAL OF NEURO-ONCOLOGY
- Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer
- (2011) Jieun Yun et al. EMBO JOURNAL
- O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients
- (2011) S. Spiegl-Kreinecker et al. NEURO-ONCOLOGY
- Identification of Senescence-Associated Genes and Their Networks Under Oxidative Stress by the Analysis of Bach1
- (2010) Kazushige Ota et al. ANTIOXIDANTS & REDOX SIGNALING
- Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells
- (2010) T Kato et al. GENE THERAPY
- The Correlation between Promoter Methylation Status and the Expression Level of O6-Methylguanine-DNA Methyltransferase in Recurrent Glioma
- (2010) Tomohide Suzuki et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Sensitivity to temozolomide in brain tumor initiating cells
- (2010) M. D. Blough et al. NEURO-ONCOLOGY
- Standard Therapy for Glioblastoma— A Review of Where We Are
- (2010) Ryo NISHIKAWA NEUROLOGIA MEDICO-CHIRURGICA
- Advances in the Treatment of Malignant Gliomas
- (2010) Mustafa Khasraw et al. Current Oncology Reports
- Temozolomide in malignant gliomas: current use and future targets
- (2009) J. Lee Villano et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
- (2008) Monika E. Hegi et al. JOURNAL OF CLINICAL ONCOLOGY
- Bach1 inhibits oxidative stress–induced cellular senescence by impeding p53 function on chromatin
- (2008) Yoshihiro Dohi et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now